Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
about
Rapid renal alpha-1 antitrypsin gene induction in experimental and clinical acute kidney injuryZ α-1 antitrypsin deficiency and the endoplasmic reticulum stress response.Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency.
P2860
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
@en
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
@nl
type
label
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
@en
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
@nl
prefLabel
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
@en
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
@nl
P2093
P2860
P1476
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
@en
P2093
Caitriona McLean
Catherine M Greene
Noel G McElvaney
P2860
P577
2009-07-13T00:00:00Z